BryoLogyx Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
BryoLogyx General Information
Description
Operator of a clinic-ready biotech company intended to assist in cancer immunotherapies to identify and kill cancer cells that are not visible. The company's platform applies bryostatin technology which activates and sensitizes, cells resulting in heightened immune recognition and clearance by immunotherapeutic agents and innate host immune mechanisms, enabling hospitals to enhance the performance of immuno-oncology agents, immune checkpoint inhibitors, and monoclonal antibodies.
Contact Information
Website
www.bryologyx.comCorporate Office
- 2485 Holly Oak Drive
- Danville, CA 94506
- United States
Corporate Office
- 2485 Holly Oak Drive
- Danville, CA 94506
- United States
BryoLogyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Secondary Transaction - Private | 01-Jun-2025 | Completed | Clinical Trials - Phase 1 | |||
| 2. Later Stage VC | 14-Jul-2023 | Cancelled | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC | 06-Dec-2018 | Completed | Pre-Clinical Trials |
BryoLogyx Comparisons
Industry
Financing
Details
BryoLogyx Competitors (1)
One of BryoLogyx’s competitors is SpringWorks Therapeutics, a Formerly VC-backed company based in Stamford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| SpringWorks Therapeutics | Formerly VC-backed | Stamford, CT |
BryoLogyx Patents
BryoLogyx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4472626-A1 | Method of administration of bryostatin for the induction of tumor associated antigens | Pending | 31-Jan-2022 | ||
| EP-4472626-A4 | Method of administration of bryostatin for the induction of tumor associated antigens | Pending | 31-Jan-2022 | ||
| US-20250134848-A1 | Method of administration of bryostatin for the induction of tumor associated antigens | Pending | 31-Jan-2022 | ||
| WO-2023147118-A1 | Method of administration of bryostatin for the induction of tumor associated antigens | Inactive | 31-Jan-2022 | ||
| WO-2023147118-A9 | Method of administration of bryostatin for the induction of tumor associated antigens | Inactive | 31-Jan-2022 | A61K31/35 |
BryoLogyx Signals
BryoLogyx FAQs
-
When was BryoLogyx founded?
BryoLogyx was founded in 2016.
-
Where is BryoLogyx headquartered?
BryoLogyx is headquartered in Danville, CA.
-
What is the size of BryoLogyx?
BryoLogyx has 3 total employees.
-
What industry is BryoLogyx in?
BryoLogyx’s primary industry is Drug Discovery.
-
Is BryoLogyx a private or public company?
BryoLogyx is a Private company.
-
What is BryoLogyx’s current revenue?
The current revenue for BryoLogyx is .
-
Who are BryoLogyx’s competitors?
SpringWorks Therapeutics is a competitor of BryoLogyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process